Literature DB >> 22828773

Aerobic exercise prescription in patients with chronic heart failure: a review in the beta-blocker era.

Vitor Oliveira Carvalho1.   

Abstract

Aerobic exercise training is a well-established nonpharmacological tool in patients with clinically stable chronic heart failure. In recent years, β-blocker therapy has become a primary pharmacologic intervention in patients with chronic heart failure. Despite the undeniable improvements in patients, the β-blocker era has aroused uncertainties about aerobic exercise intensity prescription. It is well known that aerobic exercise prescription is performed by a percentage of the patient's heart rate reserve and the use of β-blockers could interfere in this method. For this reason, the aim of this review is to provide an update about aerobic exercise prescription in patients with chronic heart failure who are using β-blockers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828773     DOI: 10.2459/JCM.0b013e328356a3b2

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  1 in total

1.  Puerarin inhibits apoptosis and inflammation in myocardial cells via PPARα expression in rats with chronic heart failure.

Authors:  Le He; Tong Wang; Bing-Wei Chen; Feng-Min Lu; Jing Xu
Journal:  Exp Ther Med       Date:  2019-09-06       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.